NYSE · PHR
Healthcare · Medical - Healthcare Information Services
$12.28
Down-$0.34 (-2.69%)
Updated Aug 16, 2026, 7:55 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PHR closed at $12.28 after 20 trading sessions, up 14.98% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $12.69 | $12.69 | $12.26 | $12.28 | 436.67K |
| Aug 13, 2026 | $12.34 | $12.67 | $12.22 | $12.62 | 491.56K |
| Aug 12, 2026 | $12.11 | $12.27 | $11.91 | $12.26 | 450.62K |
| Aug 11, 2026 | $12.29 | $12.645 | $12.19 | $12.27 | 747.76K |
| Aug 10, 2026 | $12.35 | $12.52 | $12.23 | $12.44 | 543.53K |
| Aug 7, 2026 | $12.60 | $13.01 | $12.405 | $12.51 | 1.13M |
| Aug 6, 2026 | $11.32 | $11.495 | $11.214 | $11.42 | 788.67K |
| Aug 5, 2026 | $11.49 | $11.52 | $11.21 | $11.49 | 627.19K |
| Aug 4, 2026 | $11.08 | $11.495 | $11.08 | $11.44 | 784.16K |
| Aug 3, 2026 | $10.99 | $11.39 | $10.9449 | $11.30 | 1.04M |
| Jul 31, 2026 | $10.54 | $10.81 | $10.425 | $10.73 | 660.59K |
| Jul 30, 2026 | $10.82 | $10.8469 | $10.1722 | $10.61 | 1.06M |
| Jul 29, 2026 | $10.87 | $11.23 | $10.81 | $11.14 | 586.49K |
| Jul 28, 2026 | $10.79 | $10.94 | $10.64 | $10.86 | 703.53K |
| Jul 27, 2026 | $10.38 | $10.82 | $10.38 | $10.63 | 825.39K |
| Jul 24, 2026 | $9.95 | $10.345 | $9.881 | $10.22 | 895.77K |
| Jul 23, 2026 | $10.11 | $10.235 | $9.67 | $9.80 | 677.98K |
| Jul 22, 2026 | $10.64 | $10.64 | $9.955 | $10.01 | 691.37K |
| Jul 21, 2026 | $10.37 | $10.74 | $10.37 | $10.60 | 584.28K |
| Jul 20, 2026 | $10.58 | $10.745 | $10.4301 | $10.68 | 499.66K |
The latest Smart Investors Daily articles mentioning PHR.
PHR research
Company profile and research snapshot.
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 29, 2026 | Truist Securities | Hold | — |
| May 28, 2026 | DA Davidson | Buy | — |
| May 28, 2026 | Citigroup | Neutral | — |
| May 28, 2026 | Canaccord Genuity | Buy | — |
| May 20, 2026 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Aug 6, 2026
ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.
Yahoo · Aug 6, 2026
Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Aug 6, 2026
Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
SeekingAlpha · Jun 15, 2026
Phreesia downgraded to Hold as EBITDA and free cash flow rise, but revenue growth slows. Click here to read more about the PHR stock.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PHR.
